Published in Ecancermedicalscience on December 07, 2016
Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med (2010) 29.06
Surgeon volume and operative mortality in the United States. N Engl J Med (2003) 16.97
Genomic analyses identify molecular subtypes of pancreatic cancer. Nature (2016) 2.70
Biology and management of pancreatic cancer. Gut (2007) 2.53
Management of adenocarcinoma of the body and tail of the pancreas. Ann Surg (1996) 1.93
Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial. Lancet (2013) 1.76
Cancer cachexia: developing multimodal therapy for a multidimensional problem. Eur J Cancer (2008) 1.67
Investigation of the incidence of pancreatic cancer-related depression and its relationship with the quality of life of patients. Digestion (2010) 1.60
Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas. Gut (2005) 1.46
Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg (2008) 1.29
Cancer cachexia: impact, mechanisms and emerging treatments. J Cachexia Sarcopenia Muscle (2012) 1.21
Indigenous inequalities in cancer: what role for health care? ANZ J Surg (2012) 1.01
Bile acid malabsoption: a forgotten diagnosis? Clin Med (2010) 0.95
Supportive and palliative care of pancreatic cancer. JOP (2007) 0.95
Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region. Gut (1998) 0.94
Review article: enzyme supplementation in cystic fibrosis, chronic pancreatitis, pancreatic and periampullary cancer. Aliment Pharmacol Ther (2010) 0.92
Guidance on the management of diarrhoea during cancer chemotherapy. Lancet Oncol (2014) 0.90
Developing a core set of patient-reported outcomes in pancreatic cancer: A Delphi survey. Eur J Cancer (2016) 0.88
Preoperative body composition is influenced by the stage of operable pancreatic adenocarcinoma but does not predict survival after Whipple's procedure. HPB (Oxford) (2010) 0.87
Establishing a cancer nutrition rehabilitation program (CNRP) for ambulatory patients attending an Australian cancer center. Support Care Cancer (2010) 0.83
Microbiota and radiation-induced bowel toxicity: lessons from inflammatory bowel disease for the radiation oncologist. Lancet Oncol (2014) 0.83
Small intestine bacterial overgrowth: an underdiagnosed cause of diarrhea in patients with pancreatic cancer. JOP (2009) 0.82
Palliative care and the aggressiveness of end-of-life care in patients with advanced pancreatic cancer. J Natl Cancer Inst (2015) 0.82
Ethnic disparity of pancreatic cancer in New Zealand. Int J Gastrointest Cancer (2002) 0.82
Pancreatic cancer and supportive care--pancreatic exocrine insufficiency negatively impacts on quality of life. Support Care Cancer (2013) 0.81
Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency. Pancreatology (2015) 0.79
Cancer mortality and incidence trends comparing New Zealand and Australia for the period 2000-2007. N Z Med J (2014) 0.78
Refining the care of patients with pancreatic cancer: the AGITG Pancreatic Cancer Workshop consensus. Med J Aust (2016) 0.78
A systematic review and thematic synthesis of quality of life in the informal carers of cancer patients with cachexia. Palliat Med (2015) 0.77
Pancreatic cancer: gradual rise, increasing relevance. Med J Aust (2015) 0.77
The holistic management of consequences of cancer treatment by a gastrointestinal and nutrition team: a financially viable approach to an enormous problem? Clin Med (2016) 0.76
Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study. Support Care Cancer (2016) 0.76
The palatability of oral nutritional supplements: before, during, and after chemotherapy. Support Care Cancer (2016) 0.76